vimarsana.com

Page 3 - ஹிட்ச்காக் நோரிஸ் பருத்தி புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Beckoning tourists, evangelical outreach, vaccine sweeteners: News from around our 50 states

Beckoning tourists, evangelical outreach, vaccine sweeteners: News from around our 50 states
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Cancer research fundraiser to hold in-person golfing, walk

Study underway to use estrogen to target drug-resistant breast cancer

Study underway to use estrogen to target drug-resistant breast cancer NORRIS COTTON CANCER CENTER LEBANON, NH –  Researchers at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) hope to make estrogen therapy a more accessible treatment option for advanced breast cancer patients. Anti-estrogen treatments, which block growth signals from estrogen receptors in tumors, are effective treatments for estrogen receptors + breast cancer. But it is common for breast tumors to become resistant to anti-estrogen treatments over time. Despite the fact that estrogen therapies are effective in some patients, estrogen therapy is rarely used. An ongoing clinical trial at NCCC will determine whether the strategy of cycling between estrogen therapy and anti-estrogen therapies is effective in human patients with advanced breast cancer. 

Using estrogen to target drug-resistant breast cancer in mice

Using estrogen to target drug-resistant breast cancer in mice Researchers at Dartmouth s and Dartmouth-Hitchcock s Norris Cotton Cancer Center (NCCC) hope to make estrogen therapy a more accessible treatment option for breast cancer patients who could benefit from it. Anti-estrogen treatments, which block growth signals from estrogen receptors (ER) in tumors, are effective treatments for ER+ breast cancer. But it is common for breast tumors to become resistant to anti-estrogen treatments over time. The research team, led by molecular biologist Todd Miller, PhD, and Nicole Traphagen, a PhD candidate in the Miller Laboratory, found that in mice, cycling between estrogen treatment and anti-estrogen treatment at a specific point in time can dramatically increase the duration of tumor regression.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.